June Almenoff

Dr. June S.
Almenoff is an Independent Director at Actinium Pharmaceuticals, Inc. and an Independent Director at Tenax Therapeutics, Inc. She is on the Board of Directors at Actinium Pharmaceuticals, Inc. and Tenax Therapeutics, Inc. Dr. Almenoff was previously employed as an Independent Director by Avalo Therapeutics, Inc., a Chief Medical Officer by RedHill Biopharma Ltd., a Chief Operating & Medical Officer by Innovate Biopharmaceuticals, Inc., an Independent Director by Brainstorm Cell Therapeutics, Inc., an Independent Non-Executive Director by TiGenix NV, an Independent Director by Ohr Pharmaceutical, Inc., a President, CEO, Director & Chief Medical Officer by Furiex Pharmaceuticals, Inc., a Vice President-Clinical Safety Organization by GlaxoSmithKline LLC, and a Member by Infectious Diseases Society of America.
She also served on the board at Kurome Therapeutics, Inc. and RDD Pharma Ltd. She received her undergraduate degree from Smith College and a doctorate degree from Icahn School of Medicine at Mount Sinai.